On the other hand, GPR32 has a putative agonist called resolvin D1 (RvD1) with highaffinity binding, which has been connected to regulate leukocyte responses, includingenhancing macrophage phagocytosis.87 RvD1 further has been correlatedwith anti-inflammatory responses as well as decreasing cancer growth by stimulatingmonocytes.88 In this case, the downregulation of GPR32 couldpotentially have some crucial roles in ALL. This evidence concerns the gene GPR32 and cancer.